USALCO, LLC has appointed Melinda Burn as Chief Technology and Innovation Officer (CTIO) to lead New Product Introduction and Research and Development initiatives. Melinda's extensive experience aligns with USALCO's vision to enhance water treatment through innovation and sustainability.
Read More
RLTR surpasses tech heavyweights Microsoft (MSFT), NVIDIA (NVDA), Alphabet (GOOGL), Amazon (AMZN), Meta (META), AMD, and Palantir (PLTR), so Far This week.
Read More
SOLO™'s Non-Proliferation Approach Aligns with U.S. NRC's Proposed Licensing Framework Criteria for Low Risk, Proliferation-Resistant Micro Modular Reactors
Read More
Startup Introduces AI-Powered Voice-Based Cognitive Screening and Care Planning Platform, Guided by Expert in Aging, Neuropsychology and Implementation Science
Read More
Whether it involves the DEA's much-publicized marijuana rescheduling efforts or MMJ BioPharma's lawful pursuit of a federal registration to conduct FDA-authorized clinical trials, one immovable obstacle remains: the DEA's constitutionally defective administrative adjudication system. Presided over by Chief Administrative Law Judge John J. Mulrooney II, this internal tribunal-often referred to as a "kangaroo court"-violates foundational principles of due process and Article II of the U.S. Constitution.
Read More
Intnt gives brands a turnkey, expert-led growth solution - delivering privacy-safe, high-intent customers with the efficiency and scale of an internal team, minus the fixed costs.
Read More
Illinois Media School - Chicago has earned the prestigious title of top-rated media trade school in USA TODAY's "America's Top Vocational Schools 2025" rankings under Communication, Journalism, and Related Programs.
Read MoreAn attempted identity theft is more than a close call-it's a serious warning. With reports sharply rising, Petroff Amshen LLP explains how a timely Identity Theft Check and credit report review can help prevent further misuse of personal information.
Read More
N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.
Using eXoZymes' AI-driven platform, a new and proprietary approach to biomanufacturing of NCT - with all the scale-up advantages of an exozyme biosolution - has been developed: Progressing from concept to lab scale validation with gram-scale production in only 5 months and at a fraction of normal SynBio R&D cost.
NCTx was created as a spin-out company to commercialize the NCT technology and is now able to provide early access partners, under material transfer agreement with product samples. NCTx and eXoZymes are actively looking to increase the number of partners.
